Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam vs Phenytoin for Nonconvulsive Electrographic Seizures
NCT02088957Phase 2Terminated
- Sponsor
- UCB
- Start
- Mar 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of brivaracetam in nonconvulsive status epilepticus (NCSE) (2 arms), sponsored by UCB. Primary endpoint: Percentage of Subjects With Seizure Freedom for 12 Hours. Started Mar 2014; status: terminated.
02
Drugs
brivaracetam
03
Conditions
nonconvulsive status epilepticus (NCSE)
Beyond the preview
Go deeper on NCT02088957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02088957.